MEDIAN DIAGNOSTICSMEDIAN DIAGNOSTICSMEDIAN DIAGNOSTICS

MEDIAN DIAGNOSTICS

No trades
See on Supercharts

233250 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Immunological Diagnosis, Molecular Diagnostics, POCT Diagnosis, and Biologicals. The Immunological Diagnosis business division focuses on fluorescent labels, enzymes, and other chemical indicators to detect and quantify the analyte. The Molecular Diagnostics business division refers to tests for unique nucleic acid sequences present in pathogenic microorganisms. The POCT Diagnosis business division consists of rapid kits for human and animal diagnostics. The Biologicals business division includes raw materials for human and animal diagnostics. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
233250 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company